GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
GSK's market cap was $101.81B on Oct 19, 2026, against $97.05B a year earlier. Over the last 5 years it ranged from $59.63B to $122.46B, with a median of $84.03B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $101.81B | +0.2% |
| 2025 | Dec 31, 2025 | $101.56B | +46.1% |
| 2024 | Dec 31, 2024 | $69.52B | -8.1% |
| 2023 | Dec 29, 2023 | $75.68B | +6.3% |
| 2022 | Dec 30, 2022 | $71.19B | -34.7% |
| 2021 | Dec 31, 2021 | $108.94B | +20.4% |
| 2020 | Dec 31, 2020 | $90.52B | -21.0% |
| 2019 | Dec 31, 2019 | $114.55B | +23.7% |
| 2018 | Dec 31, 2018 | $92.59B | +8.4% |
| 2017 | Dec 29, 2017 | $85.39B | -7.5% |
| 2016 | Dec 30, 2016 | $92.31B | – |